Colorectal Carcinoma: Is There Any Correlation between Her2/neu Expression, Ki-67 Score, and Tumor Budding and Clinicopathological Parameters?-A Prospective Institution-Based Study

被引:0
|
作者
Khan, Susnata [1 ]
Dasgupta, Senjuti [2 ]
Deb, Asit Ranjan [3 ]
机构
[1] Midnapore Med Coll & Hosp, Dept Pathol, Midnapore, West Bengal, India
[2] Med Coll, Dept Pathol, Kolkata, West Bengal, India
[3] Med Coll, Dept Radiotherapy, Kolkata, West Bengal, India
关键词
colorectal carcinoma; Her2/neu; Ki-67; tumor budding; tumor-infiltrating lymphocytes; INFILTRATING LYMPHOCYTES; CANCER;
D O I
10.1055/s-0044-1789276
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives Colorectal cancer is one of the most frequent cancers worldwide and is still a major cause of cancer mortality. Her2/neu, Ki67 score, and tumor budding are independent prognostic factors in colorectal carcinomas. The objectives of the study were to evaluate Her2/neu expression, Ki67 score, and tumor budding index at invasive margin in colorectal carcinoma and find out their possible correlations with different clinicopathological factors. Materials and Methods An institution-based observational cross-sectional study was conducted for 18 months. Forty-one patients with histologically proven diagnosis of colorectal carcinoma were included. Histopathological and immunohistochemical analyses (Her2/neu and Ki-67) of each case were done. Statistical Analysis Data analysis was done using the SPSS software. Results A significant correlation was found between tumor budding status and pathological T stage, Dukes' and American Joint Committee on Cancer stages, and between tumor-infiltrating lymphocytes status and Ki-67 expression status (p < 0.05). Conclusion The prognostic importance of tumor budding in colorectal carcinoma is very clear. Considering the small sample size of the present study, the prognostic values of Her2/neu and Ki-67 are required to be explored further in larger cohorts in the future.
引用
收藏
页数:5
相关论文
共 35 条
  • [21] A Prospective Multi-Institutional Observational Study on ER, PR, HER2/NEU, and Ki-67 Expression and Discordance Pattern in Primary and Metastatic and Recurrent Carcinoma Breast and Its Therapeutic Implications and Prognostic Outcome
    Satishkumar, Maheswaran
    Ramesh, Muthuvel
    Sanjive, Jeevan G.
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2023, 14 (01) : 72 - 80
  • [22] A Prospective Multi-Institutional Observational Study on ER, PR, HER2/NEU, and Ki-67 Expression and Discordance Pattern in Primary and Metastatic and Recurrent Carcinoma Breast and Its Therapeutic Implications and Prognostic Outcome
    Maheswaran Satishkumar
    Muthuvel Ramesh
    Jeevan G. Sanjive
    Indian Journal of Surgical Oncology, 2023, 14 : 72 - 80
  • [23] Estrogen and Progesterone Receptors Expression in 2053 HER2 Negative Invasive Breast Cancer: Correlation With Ki-67, p53 and Tumor Grade
    Saluja, Karan
    Christie, Alana
    Peng, Yan
    Fang, Yisheng
    Sarode, Venetia R.
    LABORATORY INVESTIGATION, 2015, 95 : 64A - 64A
  • [24] Estrogen and Progesterone Receptors Expression in 2053 HER2 Negative Invasive Breast Cancer: Correlation With Ki-67, p53 and Tumor Grade
    Saluja, Karan
    Christie, Alana
    Peng, Yan
    Fang, Yisheng
    Sarode, Venetia R.
    MODERN PATHOLOGY, 2015, 28 : 64A - 64A
  • [25] Male breast carcinoma: Correlation of ER, PR, Ki-67, Her2-neu, and p53 with treatment and survival, a study of 65 cases
    Wang-Rodriguez, J
    Cross, K
    Gallagher, S
    Djahanban, M
    Armstrong, JM
    Wiedner, N
    Shapiro, DH
    MODERN PATHOLOGY, 2002, 15 (08) : 853 - 861
  • [26] Analysis of HER-2/neu amplification in endometrial carcinoma by chromogenic in situ hybridization.: Correlation with fluorescence in situ hybridization, HER-2/neu, p53 and KI-67 protein expression, and outcome
    Peiró, G
    Mayr, D
    Hillemanns, P
    Löhrs, U
    Diebold, J
    MODERN PATHOLOGY, 2004, 17 (03) : 277 - 287
  • [27] Immunohistochemical analysis of hormonal receptors, p53, ki67, and HER2/neu expression in Epithelial Ovarian Carcinoma (EOC): A descriptive study
    Garcia-Velasco, Adelaida
    Mendiola, Cesar
    Sanchez-Munoz, Alfonso
    Hernando, Susana
    del Val, Olga
    Lopez-Martin, Ana
    Quintela, Miguel
    Manso, Luis
    Ballestin, Claudio
    Cortes-Funes, Hernan
    ANNALS OF ONCOLOGY, 2004, 15 : 134 - 134
  • [28] Correlation between HER2/neu overexpression/amplification and clinicopathologic parameters in advanced gastric cancer (AGC) patients (pts):: A prospective study.
    Gravalos, C.
    Marquez, A.
    Colomer, R.
    Garcia-Carbonero, R.
    Sastre, J.
    Rivera, F.
    Saenz-Cusi, A.
    Velasco, A.
    Guzman, C.
    Jimeno, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 200S - 200S
  • [29] Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma - A prospective study
    Ma, BBT
    Poon, TCW
    To, KF
    Zee, B
    Mo, FKF
    Chan, CML
    Ho, S
    Teo, PML
    Johnson, PJ
    Chan, ATC
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2003, 25 (10): : 864 - 872
  • [30] Interrelationships Between Ki67, HER2/neu, p53, ER, and PR Status and Their Associations With Tumor Grade and Lymph Node Involvement in Breast Carcinoma Subtypes Retrospective-Observational Analytical Study
    Shokouh, Taghipour Zahir
    Ezatollah, Aalipour
    Barand, Poorya
    MEDICINE, 2015, 94 (32)